Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02734290
Title Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Providence Health & Services
Age Groups: adult
Covered Countries USA

No variant requirements are available.